Literature DB >> 16574714

Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population.

Kim Wolff1, E M Tsapakis, A R Winstock, D Hartley, D Holt, M L Forsling, Katherine J Aitchison.   

Abstract

Despite the common use of MDMA (ecstasy) in the UK, the mechanism underlying associated potentially fatal cerebral oedema is unclear. We used a new experimental approach working directly with clubbers to perform a study on 30 (17 male) experienced clubbers (mean 6.6 years of clubbing). Pre- and post-clubbing measurements were performed to compare plasma levels of pituitary hormones (vasopressin, oxytocin), plasma and urine osmolality, urinary pH, and plasma sodium and urea. Ecstasy consumption was confirmed by using urinary drug screening pre- and post-clubbing. MDMA was detected in the urine samples of 17 subjects, three of which tested positive during pre-clubbing tests. Mean plasma vasopressin concentration increased in the MDMA group (1.28 +/- 0.29 to 1.43 +/- 0.41 pmol/l), but fell in other participants (1.23 +/- 0.42 to 1.16 +/- 0.0.34 pmol/l). Similarly, mean plasma oxytocin concentrations increased after ingestion of MDMA (2.02 +/- 0.29 to 2.43 +/- 0.24 pmol/l), but fell in the group that did not use MDMA (2.17 +/- 0.36 pmol/l to 1.89 +/- 0.37 pmol/l). There was a significant group by time interaction for plasma osmolality and plasma sodium (p = 0.001 and p = 0.003, respectively) and between change in urinary osmolality (p < 0.001) and MDMA use, with the pattern of change being consistent with the induction of inappropriate vasopressin secretion (also known as SIADH) by MDMA. This report demonstrates SIADH in ecstasy-using "clubbers", which has important clinical implications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574714     DOI: 10.1177/0269881106061514

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  30 in total

1.  Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin.

Authors:  Angela Szeto; Philip M McCabe; Daniel A Nation; Benjamin A Tabak; Maria A Rossetti; Michael E McCullough; Neil Schneiderman; Armando J Mendez
Journal:  Psychosom Med       Date:  2011-06-02       Impact factor: 4.312

2.  Ecstacy-associated hyponatremia: why are women at risk?

Authors:  Michael L Moritz; Kamyar Kalantar-Zadeh; Juan Carlos Ayus
Journal:  Nephrol Dial Transplant       Date:  2013-06-26       Impact factor: 5.992

3.  MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions.

Authors:  Cédric M Hysek; Gregor Domes; Matthias E Liechti
Journal:  Psychopharmacology (Berl)       Date:  2012-01-27       Impact factor: 4.530

Review 4.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

Review 5.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

6.  Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.

Authors:  Petra S van Nieuwenhuijzen; Leonora E Long; Glenn E Hunt; Jonathon C Arnold; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2010-08-21       Impact factor: 4.530

7.  MDMA decreases the effects of simulated social rejection.

Authors:  Charles G Frye; Margaret C Wardle; Greg J Norman; Harriet de Wit
Journal:  Pharmacol Biochem Behav       Date:  2013-12-03       Impact factor: 3.533

Review 8.  The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.

Authors:  James P Burkett; Larry J Young
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

Review 9.  From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

Authors:  I S McGregor; P D Callaghan; G E Hunt
Journal:  Br J Pharmacol       Date:  2008-05       Impact factor: 8.739

Review 10.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.